Sanofi Stock price

Equities

SAN

FR0000120578

Pharmaceuticals

Real-time Euronext Paris 07:16:27 2024-03-19 am EDT 5-day change 1st Jan Change
87.19 EUR -0.92% Intraday chart for Sanofi -1.30% -2.86%
Sales 2024 * 46.45B 50.36B Sales 2025 * 50.24B 54.47B Capitalization 110B 119B
Net income 2024 * 7.34B 7.96B Net income 2025 * 8.68B 9.41B EV / Sales 2024 * 2.52 x
Net Debt 2024 * 6.96B 7.54B Net Debt 2025 * 2.42B 2.62B EV / Sales 2025 * 2.24 x
P/E ratio 2024 *
14.6 x
P/E ratio 2025 *
12.4 x
Employees 86,088
Yield 2024 *
4.36%
Yield 2025 *
4.73%
Free-Float 87.77%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.44%
1 week-0.83%
Current month-0.32%
1 month+1.61%
3 months-1.48%
6 months-14.19%
Current year-2.40%
More quotes
1 week
87.22
Extreme 87.22
89.47
1 month
86.03
Extreme 86.03
90.42
Current year
84.93
Extreme 84.93
96.50
1 year
80.60
Extreme 80.6
105.18
3 years
76.45
Extreme 76.45
106.66
5 years
67.65
Extreme 67.65
106.66
10 years
62.50
Extreme 62.5
106.66
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 19-08-31
Director of Finance/CFO 59 18-09-30
Chief Tech/Sci/R&D Officer - 16-08-31
Members of the board TitleAgeSince
Director/Board Member 70 14-04-30
Director/Board Member 64 20-05-21
Director/Board Member 52 20-04-27
More insiders
Date Price Change Volume
24-03-19 87.19 -0.92% 195 664
24-03-18 88 -0.23% 813,952
24-03-15 88.2 -0.01% 3,106,988
24-03-14 88.21 -0.32% 1,249,466
24-03-13 88.49 +0.17% 1,017,214

Real-time Euronext Paris, March 19, 2024 at 06:51 am EDT

More quotes
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (71.4%): prescription drugs in the areas of specialty medicine (54.7% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (45.3%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (16.8%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (11.8%). At the end of 2022, the group had 59 production sites throughout the world. Net sales are distributed geographically as follows: France (5.3%), Europe (18%), the United States (42.5%), China (7.3%), Japan (3.8%), Brazil (2.1%), Russia (1.5%) and other (19.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
88 EUR
Average target price
107.6 EUR
Spread / Average Target
+22.30%
Consensus
  1. Stock
  2. Equities
  3. Stock Sanofi - Euronext Paris